Vol 62, No 1 (2005)
Other
Published online: 2005-12-12
Page views 379
Article views/downloads 0
Get Citation

Connect on Social Media

Connect on Social Media

Aspirin resistance in ischaemic heart disease

Wiktor Kuliczkowski, Bogumił Halawa, Bożena Korolko, Walentyna Mazurek
DOI: 10.33963/v.kp.81801
Kardiol Pol 2005;62(1):20-25.

Abstract

Background: In spite of the usage of acetylsalicylic acid (aspirin) in the secondary prevention of ischaemic heart disease (IHD), new thrombo-embolic events occur in more than half of patients. Aspirin resistance may be partially responsible for this phenomenon.
Aim: To assess the prevalence of aspirin resistance in patients with IHD and to correlate this phenomenon with the progression of atherosclerosis, concomitant diseases and other medication.
Methods: The study group consisted of 205 patients (mean age 65.8 years, 95 females) with stable angina, recent coronary angiography and positive result of non-invasive stress tests, treated with 75 mg of aspirin for at least one week. Platelet aggregation was measured using the optical aggregation method. Aspirin resistance was defined as a mean collagenand ATP-induced platelet aggregation >70%.
Results: Aspirin resistance was found in 41 (20%) patients and was significantly associated with previous coronary artery bypass grafting (CABG) (p<0.01) and three-vessel disease (p<0.05). Previous CABG was the only independent risk factor for the presence of aspirin resistance (OR 5.6; 95% CI 2.0-15.4; p<0.01).
Conclusions: Aspirin resistance is present in 20% of patients with stable angina. Previous CABG is an independent risk factor of this phenomenon.